Saturday 17 October 2026
Export GNTA’s income statement to Excel — free account
Genenta Science S.p.A. Unsponsored ADR
GNTA Healthcare Biotechnology
0.68
0.01
+1.49%
Follow GNTA
Genenta Science S.p.A. Unsponsored ADR (GNTA) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| IRLA Quince Therapeutics, Inc. compare | n/m |
| CRVO CervoMed Inc. compare | n/m |
| ALGS Aligos Therapeutics, Inc. compare | n/m |
| GRDX GridAI Technologies Corp. compare | n/m |
| NXTC NextCure, Inc. compare | n/m |
| MGX Metagenomi Therapeutics, Inc. compare | n/m |
| BCTX BRIACELL THERAP compare | 1.5× |
| ATNM Actinium Pharmaceuticals, Inc. compare | 3.1× |
| GNTA Genenta Science S.p.A. Unsponsored ADR | — |
| Biotechnology industry median | 8.5× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)